8/29/2023, 1:54 PM (Source: TeleTrader)
more TeleTrader news

US gov't reveals drugs subject to Medicare price debate

The Biden administration announced on Tuesday in a statement the first 10 drugs that are eligible for Medicare price negotiation.

Among them are Eliquis and Xarelto, used for blood clot prevention; Jardiance and Januvia, used to lower blood sugar; Farxiga, used for type 2 diabetes treatment; Entresto, used in the fight against heart failure; Enbrel, used for rheumatoid arthritis treatment; Imbruvica, used for blood cancer treatments; Stelara, which helps treat Crohn's disease; and insulins made by Novo Nordisk.

Big Pharma previously filed lawsuits against the United States government, arguing that price negotiation hinders innovation, which is in the end detrimental to customers. Meanwhile, the White House dismissed the claims, calling them false.

Baha Breaking News (BBN) / AY